Sponsored By

Planning for the FuturePlanning for the Future

March 1, 2006

1 Min Read
Planning for the Future

Originally Published MX March/April 2006


Johnson & Johnson (J&J; New Brunswick, NJ) has completed its acquisition of insulin-delivery company Animas Corp. (West Chester, PA) in a transaction valued at about $518 million. Animas will operate as a stand-alone entity within J&J's subsidiary LifeScan Inc. (Milpitas, CA), which manufactures blood glucose-monitoring systems.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like